等待開盤 08-21 09:30:00 美东时间
+0.060
+3.23%
今日重点评级关注:康托·菲茨杰拉德:维持Ultragenyx Pharmaceutical"超配"评级,目标价从96美元升至103美元;Canaccord Genuity:维持Ultragenyx Pharmaceutical"买入"评级,目标价从81美元升至83美元
今天 11:40
Ascendiant Capital analyst Edward Woo maintains Aemetis (NASDAQ:AMTX) with a Buy and lowers the price target from $22 to $20.
08-20 18:03
Aemetis (NASDAQ:AMTX) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.28) by 53.57 percent. This is a 68.29 percent increase over losses of $(0.41) per share from the same period last year. The company reported quarterly sales of $62.700 million which ...
08-06 20:02
Aemetis, Inc. (NASDAQ: AMTX), a diversified renewable natural gas and biofuels company, announced the Company’s subsidiary in India, Universal Biofuels, secured allocations to supply more than 18 million liters of biodiesel to India’s three government-owned Oil Marketing Companies (OMCs) during a th...
08-04 20:04
<p>Aemetis subsidiary Universal Biofuels in India secured orders to supply over 18 million liters of biodiesel to government-owned OMCs, generating $17 million in revenue. The company is also supplying private customers and expects additional orders to support India's goal of increasing biodiesel blending to 5% by 2030. Universal Biofuels, one of India's largest biodiesel producers, has expanded its Kakinada plant's capacity to 80 million gallons...
08-04 12:00
Aemetis, Inc. (NASDAQ:AMTX), a diversified renewable natural gas and biofuels company, today announced that its ethanol and renewable natural gas subsidiaries have received funds from the sales of $18 million of Section 45Z Clean Fuel Production Tax Credits. The sales include a $6 million tax credit...
07-09 20:04
Ascendiant Capital analyst Edward Woo maintains Aemetis (NASDAQ:AMTX) with a Buy and raises the price target from $21 to $22.
05-22 20:05
今日重点评级关注:Ascendiant Capital:维持IGC Pharma"买入"评级,目标价从5美元升至5.25美元;Benchmark:维持Direct Digital Holdings"投机性买入"评级,目标价从2美元升至8美元
04-09 10:15
Ascendiant Capital analyst Edward Woo maintains Aemetis (NASDAQ:AMTX) with a Buy and raises the price target from $20 to $21.
04-08 18:00